Home/Afecta Pharmaceuticals/Hal Lieberman, MHA

HL

Hal Lieberman, MHA

Chief Financial Officer

Afecta Pharmaceuticals

Therapeutic Areas

Neurology Ophthalmology Oncology Dermatology

Afecta Pharmaceuticals Pipeline

Drug	Indication	Phase
Neurology Program(s)	Neurologic disorders	Early Clinical
Ophthalmology Program(s)	Ophthalmologic disorders	Early Clinical
Oncology Program(s)	Malignant disorders	Early Clinical
Dermatology Program(s)	Dermatologic disorders	Early Clinical

Leadership Team at Afecta Pharmaceuticals

Bruce W. Kovacs, MD

Chief Executive Officer & Chief Scientific Officer

Shep Bentley, RAC

Chief Regulatory Officer

Kamron Shahbahrami, BSc

Head of BD/L, Commercial Operations & Analytics

View full Afecta Pharmaceuticals profile